In this issue of PET Clinics, guest editors Drs. Cristina Nanni, Paolo Castellucci, Stefano Fanti, and Neeta Pandit-Taskar bring their considerable expertise to the topic of Novel PET Imaging Techniques in the Management of Hematological Malignancies. Top experts in the field discuss the latest radiotracers for lymphoma and myeloma, novel quantitative imaging techniques, radioligand therapies, total body PET imaging; and more.- Contains 15 relevant, practice-oriented topics including PET imaging for therapy assessment in Hodgkin and non-Hodgkin lymphomas; symptomatic myeloma: PET, WB-MRI with DWI or both; advantages of total body PET imaging in hematological malignancies; applications of FDG-PET imaging in leukemias; PET imaging for therapy assessment in symptomatic myeloma, including Minimal Residual Disease; and more.- Provides in-depth clinical reviews on novel PET imaging techniques in the management of hematological malignancies, offering actionable insights for clinical practice.- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin’s and Non-Hodgkin LymphomasNew PET Tracers for Lymphoma
Radioligand Therapy in Lymphoma: Past, Present, and Future
Long-Axial Field-of-View PET Imaging in Patients with Lymphoma: Challenges and Opportunities
FDG-PET/CT Imaging in Chimeric Antigen Receptor-Engineered T-Cell Treatment in Patients with B-Cell Lymphoma: Current Evidence
New PET Tracers for Symptomatic Myeloma
Symptomatic Myeloma: PET, Whole-Body MR Imaging with Diffusion-Weighted Imaging or Both
Applications of 18F-Fluorodesoxyglucose PET Imaging in Leukemia
Role of Novel Quantitative Imaging Techniques in Hematological Malignancies
Lymphoma: The Added Value of Radiomics, Volumes and Global Disease Assessment
PET Imaging in Chimeric Antigen Receptor T-Cell Trafficking
Authors
Cristina Nanni Nuclear Medicine Department, Intitute of Nuclear Medicine, University of Bologna, Italy. Paolo Castellucci Nuclear MedicineAzienda Ospedaliero?Universitaria di Bologna
University of Bologna
Bologna, Italy. Stefano Fanti Nuclear Medicine
Azienda Ospedaliero-Universitaria di Bologna
University of Bologna
Bologna, Italy. Neeta Pandit-Taskar Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center New York, New York, USA.
